StockData
Bionano Genomics, Inc. logo

Bionano Genomics, Inc. (BNGO) stock

BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3083% below fair value
$0.98+0.02 (+2.50%)

Close on Nov 18, 2026Market cap $11.49MP/E –Yield –

Bionano Genomics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Bionano Genomics's operating cash flow for the twelve months ending Jun 30, 2026 was -$20.48M. For fiscal 2025 it was -$16.35M. The highest annual figure on record is -$16.35M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$16.35M–
FY2024Dec 31, 2024-$68.92M–
FY2023Dec 31, 2023-$125.18M–
FY2022Dec 31, 2022-$124.82M–
FY2021Dec 31, 2021-$71.93M–
FY2020Dec 31, 2020-$38.31M–
FY2019Dec 31, 2019-$29.53M–
FY2018Dec 31, 2018-$19.94M–
FY2017Dec 31, 2017-$20.82M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$4.67M–
Q1 FY2026Mar 31, 2026-$5.72M–
Q4 FY2025Dec 31, 2025-$4.18M–
Q3 FY2025Sep 30, 2025-$5.92M–
Q2 FY2025Jun 30, 2025-$3.49M–
Q1 FY2025Mar 31, 2025-$2.76M–
Q4 FY2024Dec 31, 2024-$6.50M–
Q3 FY2024Sep 30, 2024-$13.31M–
Q2 FY2024Jun 30, 2024-$20.98M–
Q1 FY2024Mar 31, 2024-$28.13M–
Q4 FY2023Dec 31, 2023-$29.78M–
Q3 FY2023Sep 30, 2023-$26.29M–
Q2 FY2023Jun 30, 2023-$36.70M–
Q1 FY2023Mar 31, 2023-$32.41M–
Q4 FY2022Dec 31, 2022-$34.52M–
Q3 FY2022Sep 30, 2022-$29.47M–
Q2 FY2022Jun 30, 2022-$28.33M–
Q1 FY2022Mar 31, 2022-$32.49M–
Q4 FY2021Dec 31, 2021-$25.62M–
Q3 FY2021Sep 30, 2021-$19.98M–
Q2 FY2021Jun 30, 2021-$12.42M–
Q1 FY2021Mar 31, 2021-$13.90M–
Q4 FY2020Dec 31, 2020-$12.10M–
Q3 FY2020Sep 30, 2020-$10.96M–
Q2 FY2020Jun 30, 2020-$7.22M–
Q1 FY2020Mar 31, 2020-$8.03M–
Q4 FY2019Dec 31, 2019-$9.38M–
Q3 FY2019Sep 30, 2019-$7.28M–
Q2 FY2019Jun 30, 2019-$6.32M–
Q1 FY2019Mar 31, 2019-$6.55M–
Q4 FY2018Dec 31, 2018-$4.09M–
Q3 FY2018Sep 30, 2018-$6.10M–
Q2 FY2018Jun 30, 2018-$2.97M–
Q1 FY2018Mar 31, 2018-$6.79M–
Q4 FY2017Dec 31, 2017-$2.81M–

More Bionano Genomics figures

See a number that looks wrong?